Drugs / Ritodrine
Ritodrine
also known as
DU-21220 · Luteonin · NSC-291565 · Pre-Par · Ritodrina · Ritodrine hcl · RITODRINE HYDROCHLORIDE · YTP · +1 more
Small molecule targets ADRB2 via activation
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | YUTOPAR | — | 1980-12-12 | fda.gov ↗ |
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00679705 | May → Nov 2008 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03298191 | Oct 2017 → Apr 2018 | — | Assiut University | Unknown | No outcome recorded |
| Phase not applicable1 trial · 1 missed | ||||||
| — | NCT00290173 | ? → Aug 2005 | pregnancy disorder | University of Zagreb | Completed | Missed primary |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT03040752 Comparator | Jan 2015 → Jan 2017 | — | Cairo University | Completed | No outcome recorded |
| — | NCT02538718 Comparator | Sep 2015 → Nov 2016 | — | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ritodrine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00679705 ↗ |
| Known as | DU-21220 | ChEMBL registry synonym — accepted as the source's own label CHEMBL83063 ↗ |
| Known as | Luteonin | ChEMBL registry synonym — accepted as the source's own label CHEMBL83063 ↗ |
| Known as | NSC-291565 | ChEMBL registry synonym — accepted as the source's own label CHEMBL83063 ↗ |
| Known as | Pre-Par | “Ritodrine (Pre-Par), maximum 400 µg/minute, IV” NCT00679705 ↗ |
| Known as | Ritodrina | ChEMBL registry synonym — accepted as the source's own label CHEMBL83063 ↗ |
| Known as | Ritodrine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL83063 ↗ |
| Known as | RITODRINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL83063 ↗ |
| Known as | YTP | “YTP(Ritodrine)” NCT02538718 ↗ |
| Known as | Yutopar | “who randomly assigned to have Yutopar(ritodrine) as tocolytics” NCT02538718 ↗ |
| Action | Activate | “Beta-2 adrenergic receptor agonist” CHEMBL83063 ↗ |
| Modality | Small molecule | — CHEMBL83063 ↗ |
| Route | Oral | “This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode...” NCT00290173 ↗ |
| Target | ADRB2 | “Beta-2 adrenergic receptor agonist” CHEMBL83063 ↗ |